AI assistant
RESOLUTION MINERALS LTD — Capital/Financing Update 2021
Jan 27, 2021
65717_rns_2021-01-27_50d3d51e-6550-4bb0-8433-7e69156282b2.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
28 January 2021
PLACEMENT CLEANSING NOTICE UNDER SECTION 708A(5)(E) OF THE CORPORATIONS ACT
Resolution Minerals Ltd (Company) has issued 10,000,000 fully paid ordinary shares (ASX: RML) as consideration for a project acquisition ( Issue ).
Details of the Issue
Class of securities:
Ordinary shares
ASX code of securities:
RML
Date of the issue:
28 January 2021
Total number of shares issued:
10,000,000
The Company advises that:
-
The shares offered under the Issue were issued without disclosure to investors under Part 6D.2 Corporations Act 2001 (Cth) (Corporations Act).
-
This notice is given under section 708A(5)(e) of the Corporations Act.
-
As at the date of this notice, the Company has complied with the provisions of Chapter 2M Corporations Act as they apply to Resolution Minerals and has complied with section 674 Corporations Act.
-
As at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act that has not already been disclosed to investors generally.
For further information please contact the authorising officer:
Duncan Chessell Managing Director Resolution Minerals Ltd +61 8 6118 7110 E: [email protected]
Follow RML on LinkedIn or Twitter
or visit our website www.resolutionminerals.com
==> picture [40 x 40] intentionally omitted <==
==> picture [49 x 40] intentionally omitted <==
CAPITAL STRUCTURE
BOARD
Ordinary Shares Issued 292.0 M
Options and rights Listed options 6.1 M @ 10c Listed options 74.6 M @ 12c Unlisted options 12.3 M @ 25c Unlisted options 13.4 M @ 6c Unlisted rights 9.5 M
Performance Shares Craig Farrow - Chair Class A 9.6 M Duncan Chessell - MD Class B 3.6 M Andrew Shearer - NED Jarek Kopias - Co Sec Last Capital Raise August 2020 - Placement & SPP Level 4, 29-31 King William Street $5.1M @ 7c Adelaide SA 5000
Craig Farrow - Chair Duncan Chessell - MD Andrew Shearer - NED Jarek Kopias - Co Sec